Epidemiology and clinical management of Legionnaires' disease

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 1011-1021

  Phin, Nick ^a,b   Parry Ford, Frances ^a   Harrison, Timothy ^a   Stagg, Helen R ^c   Zhang, Natalie ^e   Kumar, Kartik ^d   Lortholary, Olivier ^f   Zumla, Alimuddin ^c,g   Abubakar, Ibrahim ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF CHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; AUSTRALIA; CANADA; COMMUNITY ACQUIRED PNEUMONIA; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; EUROPE; HISTORY; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; JAPAN; LEGIONELLA; LEGIONNAIRE DISEASE; NEW ZEALAND; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH PRIORITY; REVIEW; RISK FACTOR; SINGAPORE; UNITED STATES; BACTERIUM IDENTIFICATION; CLASSIFICATION; EPIDEMIC; HEALTH; ISOLATION AND PURIFICATION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; PATHOGENICITY; TRANSMISSION; VIRULENCE;

BACTERIAL TYPING TECHNIQUES; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; VIRULENCE;

EID: 84908216723     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70713-3     Document Type: Review

References (126)

1. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977, 297:1189-1197.
2. Potts A, Donaghy M, Marley M, et al. Cluster of Legionnaires disease cases caused by Legionella longbeachae serogroup 1, Scotland, August to September 2013. Euro Surveill 2013, 18:20656.
3. McCormick D, Thorn S, Milne D, et al. Public health response to an outbreak of Legionnaires' disease in Edinburgh, United Kingdom, June 2012. Euro Surveill 2012, 17:20216.
4. Coetzee N, Duggal H, Hawker J, et al. An outbreak of Legionnaires' disease associated with a display spa pool in retail premises, Stoke-on-Trent, United Kingdom, July 2012. Euro Surveill 2012, 17:20271.
5. Legionnaires' disease in Europe Stockholm, April 2013, European Centre for Disease Prevention and ControlEuropean Centre for Disease Prevention and Control, (accessed July 24, 2013). http://ecdc.europa.eu/en/publications/Publications/legionnaires-disease-in-europe-2011.pdf.
6. Influenza vaccination coverage among health-care personnel-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011, 60:1073-1077. Centers for Disease Control and Prevention (CDC).
7. Ng V, Tang P, Jamieson F, Guyard C, Low DE, Fisman DN Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infect Dis 2009, 9:68.
8. Graham FF, White PS, Harte DJG, Kingham SP Changing epidemiological trends of legionellosis in New Zealand, 1979-2009. Epidemiol Infect 2012, 140:1481-1496.
9. Ozeki Y, Yamada F, Saito A, Kishimoto T, Tanno S, Nakamura Y Seasonal patterns of legionellosis in Saitama, 2005-2009. Jpn J Infect Dis 2012, 65:330-333.
10. Lam MC, Ang LW, Tan AL, James L, Goh KT Epidemiology and control of legionellosis, Singapore. Emerg Infect Dis 2011, 17:1209-1215.
11. Milton A, Stirzaker S, et al. Australia's notifiable disease status, 2010: annual report of the national notifiable diseases surveillance system. Commun Dis Intell Q Rep 2012, 36:1-69. NNDSS Annual Report Writing Group.
12. Legionnaires' disease in Europe Stockholm, September 2011, European Centre for Disease Prevention and ControlEuropean Centre for Disease Prevention and Control, (accessed July 24, 2013). http://ecdc.europa.eu/en/publications/Publications/1109_SR_Legionnaires'%20disease_Europe_2009.pdf.
13. Legionnaires' disease in Europe Stockholm, July 2012, European Centre for Disease Prevention and ControlEuropean Centre for Disease Prevention and Control, (accessed July 24, 2013). http://ecdc.europa.eu/en/publications/Publications/SUR-Legionnaires-disease-surveillance-2010.pdf.
14. Fisman DN, Lim S, Wellenius GA, et al. It's not the heat, it's the humidity: wet weather increases legionellosis risk in the greater Philadelphia metropolitan area. J Infect Dis 2005, 192:2066-2073.
15. Ng V, Tang P, Jamieson F, et al. Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology. EcoHealth 2008, 5:482-490.
16. Karagiannis I, Brandsema P, Van Der Sande M Warm, wet weather associated with increased Legionnaires' disease incidence in the Netherlands. Epidemiol Infect 2009, 137:181-187.
17. Ricketts KD, Charlett A, Gelb D, Lane C, Lee JV, Joseph CA Weather patterns and Legionnaires' disease: a meteorological study. Epidemiol Infect 2009, 137:1003-1012.
18. Dunn CE, Rowlingson B, Bhopal RS, Diggle P Meteorological conditions and incidence of Legionnaires' disease in Glasgow, Scotland: application of statistical modelling. Epidemiol Infect 2013, 141:687-696.
19. Hambleton P, Broster MG, Dennis PJ, Henstridge R, Fitzgeorge R, Conlan JW Survival of virulent Legionella pneumophila in aerosols. J Hyg (Lond) 1983, 90:451-460.
20. Berendt RF Survival of Legionella pneumophila in aerosols: effect of relative humidity. J Infect Dis 1980, 141:689.
21. Den Boer JW, Nijhof J, Friesema I Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study. Public Health 2006, 120:566-571.
22. Ricketts KD, Yadav R, Rota MC, Joseph CA Characteristics of reoffending accommodation sites in Europe with clusters of Legionnaires disease, 2003-2007. Euro Surveill 2010, 15:19680.
23. Beauté J, Zucs P, de Jong B Risk for travel-associated legionnaires' disease, Europe, 2009. Emerg Infect Dis 2012, 18:1811-1816.
24. Lindsay DSJ, Brown AW, Brown DJ, Pravinkumar SJ, Anderson E, Edwards GFS Legionella longbeachae serogroup 1 infections linked to potting compost. J Med Microbiol 2012, 61:218-222.
25. Amodeo MR, Murdoch DR, Pithie AD Legionnaires' disease caused by Legionella longbeachae and Legionella pneumophila: comparison of clinical features, host-related risk factors, and outcomes. Clin Microbiol Infect 2010, 16:1405-1407.
26. O'Connor BA, Carman J, Eckert K, Tucker G, Givney R, Cameron S Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect 2007, 135:34-39.
27. García-Fulgueiras A, Navarro C, Fenoll D, et al. Legionnaires' disease outbreak in Murcia, Spain. Emerg Infect Dis 2003, 9:915-921.
28. Greig JE, Carnie JA, Tallis GF, et al. An outbreak of Legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies. Med J Aust 2004, 180:566-572.
29. Bennett E, Ashton M, Calvert N, et al. Barrow-in-Furness: a large community legionellosis outbreak in the UK. Epidemiol Infect 2013, 11:1-15.
30. Colville A, Crowley J, Dearden D, Slack RC, Lee JV Outbreak of Legionnaires' disease at University Hospital, Nottingham. Epidemiology, microbiology and control. Epidemiol Infect 1993, 110:105-116.
31. Den Boer JW, Yzerman EPF, Schellekens J, et al. A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis 2002, 8:37-43.
32. O'Loughlin RE, Kightlinger L, Werpy MC, et al. Restaurant outbreak of Legionnaires' disease associated with a decorative fountain: an environmental and case-control study. BMC Infect Dis 2007, 7:93.
33. Barrabeig I, Rovira A, Garcia M, et al. Outbreak of Legionnaires' disease associated with a supermarket mist machine. Epidemiol Infect 2010, 138:1823-1828.
34. Bencini MA, Yzerman EPF, Koornstra RHT, Nolte CCM, den Boer JW, Bruin JP A case of Legionnaires' disease caused by aspiration of ice water. Arch Environ Occup Health 2005, 60:302-306.
35. Keller DW, Hajjeh R, DeMaria A, et al. Community outbreak of Legionnaires' disease: an investigation confirming the potential for cooling towers to transmit Legionella species. Clin Infect Dis 1996, 22:257-261.
36. Sabria M, Alvarez J, Dominguez A, et al. A community outbreak of Legionnaires' disease: evidence of a cooling tower as the source. Clin Microbiol Infect 2006, 12:642-647.
37. Beyrer K, Lai S, Dreesman J, et al. Legionnaires' disease outbreak associated with a cruise liner, August 2003: epidemiological and microbiological findings. Epidemiol Infect 2007, 135:802-810.
38. Nygård K, Ø Werner-Johansen, Rønsen S, et al. An outbreak of legionnaires disease caused by long-distance spread from an industrial air scrubber in Sarpsborg, Norway. Clin Infect Dis 2008, 46:61-69.
39. Mamolen M, Breiman RF, Barbaree JM, et al. Use of multiple molecular subtyping techniques to investigate a Legionnaires' disease outbreak due to identical strains at two tourist lodges. J Clin Microbiol 1993, 31:2584-2588.
40. Plouffe JF, Baird IM Lymphocyte transformation to Legionella pneumophila. J Clin Lab Immunol 1981, 5:149-152.
41. Rosmini F, Castellani-Pastoris M, Mazzotti MF, et al. Febrile illness in successive cohorts of tourists at a hotel on the Italian Adriatic coast: evidence for a persistent focus of Legionella infection. Am J Epidemiol 1984, 119:124-134.
42. Marston BJ, Lipman HB, Breiman RF Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994, 154:2417-2422.
43. Lanternier F, Tubach F, Ravaud P, et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest 2013, 144:990-998. the Research Axed on Tolerance of Biotherapies Group.
44. Dominguez A, Alvarez J, Sabria M, et al. Factors influencing the case-fatality rate of Legionnaires' disease. Int J Tuberc Lung Dis 2009, 13:407-412.
45. Glick TH, Gregg MB, Berman B, Mallison G, Rhodes WW, Kassanoff I Pontiac fever. An epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. Am J Epidemiol 1978, 107:149-160.
46. Kaufmann AF, McDade JE, Patton CM, et al. Pontiac fever: isolation of the etiologic agent (Legionella pneumophilia) and demonstration of its mode of transmission. Am J Epidemiol 1981, 114:337-347.
47. Tossa P, Deloge-Abarkan M, Zmirou-Navier D, Hartemann P, Mathieu L Pontiac fever: an operational definition for epidemiological studies. BMC Public Health 2006, 6:112.
48. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977, 297:1197-1203.
49. Wilkinson HW, Reingold AL, Brake BJ, McGiboney DL, Gorman GW, Broome CV Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis 1983, 147:23-31.
50. Harrison TG, Dournon E, Taylor AG Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella pneumophila serogroup 1. J Clin Pathol 1987, 40:77-82.
51. Harrison TG, Doshi N, Hallas G, George RC Legionella pneumophila assays: An evaluation of commercial kits and reagents for the estimation of Legionella pneumophila antibody levels. Respiratory and Systemic Infection Laboratory, Central Public Health Laboratory, January-April, 1999 (accessed Nov 1, 2013). http://www.hpa.org.uk/Publications/InfectiousDiseases/RespiratoryDiseases/9905Legionellapneumophilaantibodyassays/.
52. Marshall LE, Boswell TC, Kudesia G False positive legionella serology in campylobacter infection: campylobacter serotypes, duration of antibody response and elimination of cross-reactions in the indirect fluorescent antibody test. Epidemiol Infect 1994, 112:347-357.
53. 1996 case definition legionellosis National Notifiable Diseases Surveillance System (NNDSS), (accessed Dec 23, 2013). http://wwwn.cdc.gov/nndss/script/casedef.aspx?CondYrID=740&DatePub=1/1/1996%2012:00:00%20AM.
54. Strengthening Surveillance for Travel-Associated Legionellosis and Case Definitions for Legionellosis Position Statement CSTE, (accessed July 17, 2013). http://www.cdc.gov/legionella/health-depts/CSTE-position-statement.html.
55. 2008/426/EC: Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2008) 1589) (accessed July 17, 2013). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:159:0046:01:EN:HTML.
56. Elverdal PL, Jørgensen CS, Krogfelt KA, Uldum SA Two years' performance of an in-house ELISA for diagnosis of Legionnaires' disease: detection of specific IgM and IgG antibodies against Legionella pneumophila serogroup 1, 3 and 6 in human serum. J Microbiol Methods 2013, 94:94-97.
57. Farshy CE, Klein GC, Feeley JC Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests. J Clin Microbiol 1978, 7:327-331.
58. Plouffe JF, File TM, Breiman RF, et al. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Clin Infect Dis 1995, 20:1286-1291. the Community Based Pneumonia Incidence Study Group.
59. Harrison TG, Doshi N Evaluation of the Bartels Legionella urinary antigen enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2001, 20:738-740.
60. Domínguez J, Galí N, Matas L, et al. Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples. Eur J Clin Microbiol Infect Dis 1999, 18:896-898.
61. Helbig JH, Uldum SA, Bernander S, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol 2003, 41:838-840.
62. Svarrer CW, Lück C, Elverdal PL, Uldum SA Immunochromatic kits Xpect Legionella and BinaxNOW Legionella for detection of Legionella pneumophila urinary antigen have low sensitivities for the diagnosis of Legionnaires' disease. J Med Microbiol 2012, 61:213-217.
63. Kim MJ, Sohn JW, Park DW, Park SC, Chun BC Characterization of a lipoprotein common to Legionella species as a urinary broad-spectrum antigen for diagnosis of Legionnaires' disease. J Clin Microbiol 2003, 41:2974-2979.
64. Winn WC Legionella and the clinical microbiologist. Infect Dis Clin North Am 1993, 7:377-392.
65. Dournon E Isolation of legionellae from clinical samples. A laboratory manual for legionella 1988, 13-30. J Wiley & Son, Chichester, Chapter 5. T.G. Harrison, A.G. Taylor (Eds.).
66. Mentasti M, Fry NK, Afshar B, Palepou-Foxley C, Naik FC, Harrison TG Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires' disease. Eur J Clin Microbiol Infect Dis 2012, 31:2017-2028.
67. von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008, 46:1356-1364.
68. Lindsay DSJ, Abraham WH, Findlay W, Christie P, Johnston F, Edwards GFS Laboratory diagnosis of legionnaires' disease due to Legionella pneumophila serogroup 1: comparison of phenotypic and genotypic methods. J Med Microbiol 2004, 53:183-187.
69. Helbig JH, Engelstädter T, Maiwald M, Uldum SA, Witzleb W, Lück PC Diagnostic relevance of the detection of Legionella DNA in urine samples by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1999, 18:716-722.
70. Diederen BMW, de Jong CMA, Marmouk F, Kluytmans JAJW, Peeters MF, Van der Zee A Evaluation of real-time PCR for the early detection of Legionella pneumophila DNA in serum samples. J Med Microbiol 2007, 56:94-101.
71. Viasus D, Di Yacovo S, Garcia-Vidal C, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013, 92:51-60.
72. Chidiac C, Che D, Pires-Cronenberger S, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J 2012, 39:963-970.
73. Eliakim-Raz N, Robenshtok E, Shefet D, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2012, 9. CD004418.
74. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
75. Levy ML, Le Jeune I, Woodhead MA, Macfarlaned JT, Lim WS Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Prim Care Respir J 2010, 19:21-27.
76. Cunha BA Atypical pneumonias: current clinical concepts focusing on Legionnaires' disease. Curr Opin Pulm Med 2008, 14:183-194.
77. Zumla A, Weyell R, Tettmar RE Legionnaires' disease: early lessons from 1988 London outbreak. Lancet 1988, 1:1275.
78. Gudiol C, Garcia-Vidal C, Fernández-Sabé N, et al. Clinical features and outcomes of Legionnaires' disease in solid organ transplant recipients. Transpl Infect Dis 2009, 11:78-82.
79. Oren I, Zuckerman T, Avivi I, Finkelstein R, Yigla M, Rowe JM Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transplant 2002, 30:175-179.
80. Chow JW, Yu VL Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect 1998, 13:132-139.
81. Morley JN, Smith LC, Baltch AL, Smith RP Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clin Infect Dis 1994, 19:1130-1132.
82. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP Legionella pneumonia in cancer patients. Medicine (Baltimore) 2008, 87:152-159.
83. Griffin AT, Peyrani P, Wiemken T, Arnold F Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Int J Tuberc Lung Dis 2010, 14:495-499.
84. Mykietiuk A, Carratalà J, Fernández-Sabé N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005, 40:794-799.
85. Blázquez Garrido RM, Espinosa Parra FJ, Alemany Francés L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis 2005, 40:800-806.
86. Haranaga S, Tateyama M, Higa F, et al. Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia. Intern Med 2007, 46:353-357.
87. Garau J, Fritsch A, Arvis P, Read RC Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp. J Chemother 2010, 22:264-266.
88. Meyer RD, Finegold SM Legionnaires' disease. Annu Rev Med 1980, 31:219-232.
89. Pedro-Botet L, Yu VL Legionella: macrolides or quinolones?. Clin Microbiol Infect 2006, 12:25-30.
90. Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages. Diagn Microbiol Infect Dis 2011, 69:86-93.
91. Miller AC Erythromycin in legionnaires' disease: a re-appraisal. J Antimicrob Chemother 1981, 7:217-222.
92. Vergis EN, Indorf A, File TM, et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000, 160:1294-1300.
93. File TM, Segreti J, Dunbar L, et al. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother 1997, 41:1965-1972.
94. Dumarcet N Updates for the antibiotic treatment of legionellosis in adults. Med Mal Infect 2012, 42:393-403. 403-13.
95. Lowry PW, Tompkins LS Nosocomial legionellosis: a review of pulmonary and extrapulmonary syndromes. Am J Infect Control 1993, 21:21-27.
96. Castilla J, Barricarte A, Aldaz J, et al. A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatality. Epidemiol Infect 2008, 136:823-832.
97. Nguyen TMN, Ilef D, Jarraud S, et al. A community-wide outbreak of legionnaires disease linked to industrial cooling towers-how far can contaminated aerosols spread?. J Infect Dis 2006, 193:102-111.
98. White PS, Graham FF, Harte DJG, Baker MG, Ambrose CD, Humphrey ARG Epidemiological investigation of a Legionnaires' disease outbreak in Christchurch, New Zealand: the value of spatial methods for practical public health. Epidemiol Infect 2013, 141:789-799.
99. Shands KN, Ho JL, Meyer RD, et al. Potable water as a source of Legionnaires' disease. JAMA 1985, 253:1412-1416.
100. O'Mahony MC, Stanwell-Smith RE, Tillett HE, et al. The Stafford outbreak of Legionnaires' disease. Epidemiol Infect 1990, 104:361-380.
101. Jernigan DB, Hofmann J, Cetron MS, et al. Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet 1996, 347:494-499.
102. Okada M, Kawano K, Kura F, et al. [The largest outbreak of legionellosis in Japan associated with spa baths: epidemic curve and environmental investigation]. (In Japanese). Kansenshogaku Zasshi 2005, 79:365-374.
103. Silk BJ, Moore MR, Bergtholdt M, et al. Eight years of Legionnaires' disease transmission in travellers to a condominium complex in Las Vegas, Nevada. Epidemiol Infect 2012, 140:1993-2002.
104. Maini R, Naik F, Harrison TG, et al. Travel-associated Legionnaires disease in residents from England and Wales travelling to Corfu, Greece, August to October 2011. Euro Surveill 2012, 17:1-6.
105. Rapport du Directeur de Santé Publique, François Desbiens, MD. Éclosion de légionelles dans la ville de Québec, Québec (in French) Isabelle Goupil Sormany (2012), (accessed May, 2014). http://www.rrsss03.gouv.qc.ca/pdf/Rapport%20legionellose%20version%20FINALE%2010-12-2012.pdf.
106. Joly JR, McKinney RM, Tobin JO, Bibb WF, Watkins ID, Ramsay D Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies. J Clin Microbiol 1986, 23:768-771.
107. Helbig JH, Kurtz JB, Pastoris MC, Pelaz C, Lück PC Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups. J Clin Microbiol 1997, 35:2841-2845.
108. Afshar B, Fry NK, Bellamy W, Underwood AP, Harrison TG External quality assessment of a DNA sequence-based scheme for epidemiological typing of Legionella pneumophila by an international network of laboratories. J Clin Microbiol 2007, 45:3251-3256. the Members of the European Working Group for Legionella Infections.
109. Ginevra C, Lopez M, Forey F, et al. Evaluation of a nested-PCR-derived sequence-based typing method applied directly to respiratory samples from patients with Legionnaires' disease. J Clin Microbiol 2009, 47:981-987.
110. The South Wales "Heads of the Valleys" Legionnaires disease outbreak 2010 report of the Outbreak Control Team Public Health Wales, (accessed July 24, 2013). http://www.wales.nhs.uk/sitesplus/888/news/19874.
111. Sansom P, Copley VR, Naik FC, Leach S, Hall IM A case-association cluster detection and visualisation tool with an application to Legionnaires' disease. Stat Med 2013, 32:3522-3538.
112. Egan JR, Hall IM, Lemon DJ, Leach S Modeling Legionnaires' disease outbreaks: estimating the timing of an aerosolized release using symptom-onset dates. Epidemiology 2011, 22:188-198.
113. Harrison TG, Afshar B, Doshi N, Fry NK, Lee JV Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000-2008). Eur J Clin Microbiol Infect Dis 2009, 28:781-791.
114. Kozak-Muiznieks NA, Lucas CE, Brown E, et al. Prevalence of sequence types among clinical and environmental isolates of Legionella pneumophila serogroup 1 in the United States from 1982 to 2012. J Clin Microbiol 2014, 52:201-211.
115. Vergnes M, Ginevra C, Kay E, et al. Insertion sequences as highly resolutive genomic markers for sequence type 1 Legionella pneumophila Paris. J Clin Microbiol 2011, 49:315-324.
116. Pannier K, Heuner K, Lück C Variable genetic element typing: a quick method for epidemiological subtyping of Legionella pneumophila. Eur J Clin Microbiol Infect Dis 2010, 29:481-487.
117. Ginevra C, Jacotin N, Diancourt L, et al. Legionella pneumophila sequence type 1/Paris pulsotype subtyping by spoligotyping. J Clin Microbiol 2012, 50:696-701.
118. Reuter S, Harrison TG, Köser CU, et al. A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak. BMJ Open 2013, 3:e002175.
119. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001, 56:296-301.
120. Misch EA, Verbon A, Prins JM, Skerrett SJ, Hawn TRA A TLR6 polymorphism is associated with increased risk of Legionnaires' disease. Genes Immun 2013, 14:420-426.
121. Bull M, Hall IM, Leach S, Robesyn E The application of geographic information systems and spatial data during Legionnaires disease outbreak responses. Euro Surveill 2012, 17:20331.
122. Lock K, Millett C, Heathcock R, et al. Public health and economic costs of investigating a suspected outbreak of Legionnaires' disease. Epidemiol Infect 2008, 136:1306-1314.
123. Harrison TG, Doshi N, Fry NK, Joseph CA Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years. Clin Microbiol Infect 2007, 13:78-85.
124. Dennis PJ, Lee JV Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J Appl Bacteriol 1988, 65:135-141.
125. Helbig JH, Lück PC, Knirel YA, Witzleb W, Zähringer U Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1. Epidemiol Infect 1995, 115:71-78.
126. Stephen FR, Murray JP Prevention of hot tap water burns-a comparative study of three types of automatic mixing valve. Burns 1993, 19:56-62.